Skip to main content

Table 2 Spearman's correlation between ORIDL and SF-12, MYMOP, and PEI at GHH (study 2)

From: Outcome related to impact on daily living: preliminary validation of the ORIDL instrument

  ORIDL – main complaint ORIDL – well being
  3 months 12 months 33 months 3 months 12 months 33 months
SF-12 PCS Change 0.214* (90) 0.186 (56) 0.224 (63) 0.211* (90) 0.152 (57) 0.336** (63)
SF-12 MCS Change 0.245* (90) 0.015 (56) 0.334** (63) 0.235* (90) 0.040 (57) 0.388** (63)
MYMOP Change inProfile 0.444*** (90) 0.474*** (61) 0.499** *(68) 0.400** (99) 0.487** *(62) 0.541*** (68)
MYMOP Change in Symptoms 0.433*** (109) 0.444** *(68) 0.440 ** *(70) 0.435** *(109) 0.485*** (69) 0.446***(70)
MYMOP Change in Well-Being 0.334** (102) 0.314* (62) 0.390** (64) 0.333** (101) 0.439** *(63) 0.383** (64)
PEI Overall Outcome 0.451** (105) 0.586***(62) - 0.528*** (104) 0.640*** (63) -
  1. * p < 0.05, ** p < 0.01, *** p < 0.001